As a continuation of our interest in the anti-inflammatory activities of Vietnamese plants, we searched for novel anti-inflammatory agents in Eleutherine bulbosa and evaluated the anti-inflammatory effects of an ethanol extract of the rhizome of E. bulbosa (EBE) on lipopolysaccharide-stimulated RAW 264.7 macrophages in vitro and in a collagen antibody-induced arthritic (CAIA) mouse model in vivo. Treatment of the CAIA mice with EBE decreased the incidence of arthritis, especially at a dose of 1000 mg/kg body weight. A significant (P<0.05) decrease in the arthritis score was seen after high-dose EBE treatment between days 10 and 14 in comparison with the negative control. The serum levels of the inflammatory cytokines tumor necrosis factor alpha (TNF-α), interleukin (IL)-6, and IL-10 in the mice were measured using commercial ELISA kits. The results suggest that an ethanol extract of the E. bulbosa rhizome has beneficial effects on inflammatory cytokine regulation in an experimental CAIA model.
In Vietnamese traditional medicine, Eleutherine bulbosa (Miller) Urb. is used to treat conditions such as fatigue, anaemia, cough, and sore throat, and for its anti-inflammatory and detoxification effects [1] . In oriental medicine, it is also used to treat heart failure, cancer, intestinal disorders, skin disease, and infertility [2] . Phytochemical investigations of E. bulbosa have resulted in the identification of several aromatic compounds and their glycosides, such as eleutherinone, eleutherine, isoeleutherine, eleutherol, (R)-4-hydroxyeleutherin, eleuthone, isoeleuthoside C, and eleutherinol-8-O-β-D-glucoside [3] . Previously, we reported the isolation of a new compound dihydroeleutherinol-8-O-β-D-glucopyranoside (1) from a methanol extract of the rhizome of E. bulbosa, along with 14 other compounds: eleutherinol (2), eleutherinoside A (3), (-)-hongconin (4), eleutherin (5), isoeleutherin (6) , eleuthoside C (7), eleutherineoside C (8), eleutherinoside B (9), (R)-7-acetyl-3,6-dihydroxy-8-methyltetralone (10) , eleuthoside A (11), eleuthoside B (12) , eleutherinoside D (13), 3,6,8-trihydroxy-1-methylanthraquinone (14) , and 2-acetyl-3,6,8-trihydroxy-1-methylanthraquinone (15) . We also performed an in vitro evaluation of their inhibitory effects on the lipopolysaccharide-stimulated production of proinflammatory cytokines in bone marrow-derived dendritic cells [4] . Rheumatoid arthritis (RA) is an autoimmune disease that is characterized by synovial inflammation and cartilage and bone destruction. RA also has systemic features. The evolution of the disease is regulated by cytokines such as interleukin (IL)-1, IL-4, IL-8, IL-10, and tumor necrosis factor alpha (TNF-α). Therefore, to continue our research on the anti-inflammatory activity of E. bulbosa for use in functional foods, we describe the acute toxicity and anti-inflammatory effects of an ethanol extract of E. bulbosa (EBE) in a collagen antibody-induced arthritis (CAIA) mouse model.
Before conducting an in vivo study, the anti-inflammatory effects of EBE were checked in vitro. Our study on lipopolysaccharideinduced RAW 264.7 macrophages showed that EBE inhibited the production of nitric oxide (NO) using the Griess assay. As shown in Table 1 , the addition of 50 µg/mL EBE strongly inhibited NO release (79.49%), and cell viability was 96.57%. EBE showed potential suppression of NO with an IC 50 = 27.30 ± 2.98 µg/mL. NO plays an essential role in the function of many organs, including the immune system. However, overproduction of NO has cytotoxic, inflammatory, and autoimmune effects [5] . An increase in NO, produced by nitric oxide synthase ( iNOS), was found in the serum of RA patients [6] . It is evident that a high NO level is important in the pathology of RA and is correlated with inflammatory markers and radiological joint status in RA, causing cell and tissue damage [7, 8] . An iNOS inhibitor effectively reduced the symptoms of RA [9] . Therefore, the inhibition of NO production by EBE has therapeutic potential for the treatment of inflammatory diseases, including RA.
Before conducting the in vivo study, the acute toxicity of EBE was assessed in mice after oral administration of 1000, 2000, 3000, 4000, and 5000 mg/kg body weight (b.w.) doses. At these doses, [10] . Therefore, the results suggest that EBE is nontoxic, and the LD 50 was not determined.
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Based on the toxicity tests, two EBE doses were chosen for the anti-arthritis tests: 1000 and 500 mg/kg b.w. After injecting collagen antibody for 4 days, the mice were divided into groups and treated with EBE for 10 days. The joints of the negative control mice were swollen and red. The arthritis score of the mice was determined according to the signs of swelling and inflammation. A significant decrease in the arthritis score was seen with the highdose EBE treatment between days 10 and 14 compared with the negative control (figure 1). The swelling and redness were also reduced in the mice given EBE 1000 mg/kg b.w. In comparison, the mice given EBE 500 mg/kg b.w. had a slightly lower arthritis score at an early stage, but with no significant difference at the end of the experiment. In addition to evaluating arthritis based on the clinical findings, the histopathology of the joints was assessed. The joints of the negative control mice showed obvious edema, infiltration of inflammatory cells, and synovial hyperplasia. Treatment with EBE 1000 mg/kg b.w. reduced the edema and inflammatory cell infiltrate in the joints compared with the vehicle group (figure 2). Because arthritis involves chronic inflammation, the overproduction of proinflammatory cytokines is an important characteristic of arthritis. Therefore, the proinflammatory cytokines IL-6 and TNF-α and the anti-inflammatory cytokine IL-10 were measured in the serum of mice treated with EBE. As shown in Figure 3 , EBE 1000 mg/kg b.w. significantly (P<0.05) suppressed the production of IL-6 and TNF-α in the serum of mice compared with vehicle treatment, while the IL-10 level was increased slightly compared with the negative control mice, but the difference was not significant (P>0.05). As an autoimmune disease, the pathology of RA is related to the presence of cytokines in the joints. Cytokines are involved in the development of the immune system and induce autoimmunity. The Effects of E. bulbosa rhizome extracts on inflammatory cytokine regulation Natural Product Communications Vol. 13 (7) 2018 885 presence of cytokines causes inflammatory cells to invade cartilage, triggering a continuous inflammatory response and causing tissue destruction [11] . Cytokines play an important role in developing new therapeutic targets in pharmacology [12] . Three groups of cytokines play roles in the development of RA: proinflammatory (IL-1, IL-6, and TNF-α), anti-inflammatory (IL-4 and IL-10), and supplemental cytokines. The proinflammatory cytokines IL-6 and TNF-α contribute to the severity of RA. High levels of IL-6 are found in the blood of patients with RA [13] . The presence of IL-6 not only promotes joint and bone damage but also induces many articular and systemic manifestations, such as the anaemia of chronic inflammation, fatigue, and systemic osteoporosis [12, 14] . Similarly, TNF-α is present in the joints and blood of RA patients. TNF-α is produced mainly by macrophages and induces the synthesis and secretion of matrix-degrading proteases, prostanoids, IL-6, IL-8, and granulocyte-macrophage colony stimulating factor by synovial fibroblasts [15, 16] . Both TNF-α and IL-6 have been considered as targets for RA treatment [17, 18] . However, the use of anti-IL-6R (tocilizumab) or anti-TNF-α monoclonal antibodies in RA therapy has side effects, such as increased liver transaminase and lipid levels [13, 15] . Therefore, the development of safe, efficacious natural compounds has been considered. Previously, we reported that E. bulbosa showed potential anti-inflammatory effects by suppressing pro-cytokines such as IL-6, TNF-α, and IL-12 p40 in vitro and the main active compounds are found to be eleutherin, isoeleutherin and some eleutherinosides [4] . This study is the first report of the anti-arthritis activity of E. bulbosa in a CAIA mouse model. EBE reduced the signs of arthritis. Moreover, the activity of this plant extract was related to the suppression of proinflammatory cytokines.
Based on the effective dose of EBE (1000 mg/kg b.w.) in the treatment of CAIA, the dosage for humans can be calculated for its use as a food supplement. Nair and Jacob [19] showed a simple method to calculate the dosage for humans by calculating the human equivalent dosage (HED) as follows:
HED (mg/kg) = animal NOAEL (mg/kg) × [weight animal (kg)/weight human (kg)]
where NOAEL is the no observed adverse effect level of a drug in preclinical toxicological studies. NOAEL, the highest dose that does not cause any significant adverse effects, is a safety index determined from animal experiments that is used to determine a safe starting dose in humans. HED also can be determined using another formula based on the animal dose and the correction factor K m as follows:
Therefore, if the effective animal dose is 1000 mg/kg b.w., the animal K m is 3, and the human K m is 37; then HED = 1000 × (3/37) = 8.1 mg/kg. Cell treatment: RAW 264.7 cells were seeded in the 96 wells plated at density of 1x10 5 cells/well and incubated 24 hours before treatment. The EBE at different concentrations (50 µg/mL, 25 µg/mL, 12.5 µg/mL, 6.25 µg/mL) were then added in to the cell and incubated for 2 hours. After that, the cells were stimulated with LPS (1µg/mL) for 24 hours. The medium suspension was used for NO determination and the remain cell were used for determining the cell viability.
Experimental
The amount of nitrite oxide (NO) in suspension medium was determined by Greiss assay. In which, 100 µl suspension medium was mixed with 100 µl Griess reagent (containing 1% sulfanilamide and 0.1% naphthylethylenediamine dihydrochloride in 2.5% phosphoric acid) and then incubated at room temperature before measured the optical density (OD) at 540 nm. The amount of NO was calculated based on NaNO 2 standard curve. The inhibition percentage of NO production were calculated by following formula: % inhibition = 100%-(amount of NO in treatment wells/amount of NO in control wells)x100
For viability determining, 50 µl 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (1mg/mL) was added to the remained cells and incubated for 4 hours. The tetrazolium dye MTT will be reduced and changed to formazan in living cells. The formazan was then dissolved in DMSO and the absorbance was measured at 570 nm.
Acute toxicity assay:
The acute toxicity assay was performed following the OECD GUIDELINE 420 [10] . Mice were treated with EBE at doses of 1000, 2000, 3000, 4000 and 5000 mg/kg body weight (b.w.) after 4 h diet. They were observed for 14 days after administration of EBE. During the treatment period, behavioral parameters such as motor activity, convulsions, piloerection, salivation, and sedation were monitored.
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Anti-inflammation evaluation using model of collagen antibodyinduced arthritis (CAIA) in mice:
To accessed the antiinflammation of EBE, male BALB/c mice at 10 weeks of age were intraperitoneal injected (ip injection) with 3 mg the cocktail of anticollagen antibodies. In addition, the development of arthritis was booted with 25 μg of LPS (Sigma, St. Louis, MO) on day 3 and day 9 of experiment. On day 4, after mice had initial symptoms of arthritis, mice were divided to 4 groups (6 mice per group) and treated with drugs: the group 1 received water daily for 10 days serve as negative control; The groups 2 and 3 were orally EBE at a dose of 500 mg/kg b.w. and 1000 mg/kg b.w. daily for 10 days, respectively; the group 4 served as positive control was given dexamethasone by gavage at a dose of 0.5 mg/kg b.w. daily for 10 days. The score of clinical arthritis was examined every 2 day of experiment. Each paw was scored on a scale of 0-2 based on signs of swelling and inflammation.
Cytokine assay: At the end of experiment, individual sera were collected from each mouse (6 mice per group). The levels of examined cytokines in the sera were measured by using commercial ELISA kits (Biovision, Chester Springs, PA, USA), following the manufacturer's protocols.
Histological analyses: For histological analyses, the hind paws were collected post mortal at the end of experiment. Then all tissues were fixed immediately in 10% formalin. After decalcified, and embedded in paraffin, the joins were sectioned and stained with hematoxylin and eosin (H&E).
Statistical analysis:
The result shown as mean ± SD. Data was analyzed by GraphPad Prism 4.0 (GraphPad Software, Inc., San Diego CA). Student's t-test were used for statistical comparison among indipendent groups. In all comparisons, P<0.05 was considered statistically significant.
